Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Parkinson's Disease Dementia and Lewy Body Disease.

Sezgin M, Bilgic B, Tinaz S, Emre M.

Semin Neurol. 2019 Apr;39(2):274-282. doi: 10.1055/s-0039-1678579. Epub 2019 Mar 29. Review.

PMID:
30925619
2.

Amyloid Beta Adsorption Problem with Transfer Plates in Amyloid Beta 1-42 IVD Kits.

Dursun E, Alaylıoğlu M, Bilgiç B, Hanağası H, Gürvit H, Emre M, Gezen-Ak D.

J Mol Neurosci. 2019 Apr;67(4):534-539. doi: 10.1007/s12031-019-1261-0. Epub 2019 Jan 11.

PMID:
30635782
3.

Peripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal Dementia.

Guven G, Bilgic B, Tufekcioglu Z, Erginel Unaltuna N, Hanagasi H, Gurvit H, Singleton A, Hardy J, Emre M, Gulec C, Bras J, Guerreiro R, Lohmann E.

J Alzheimers Dis. 2019;67(1):159-167. doi: 10.3233/JAD-180599.

4.

Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale.

Akbostanci MC, Bayram E, Yilmaz V, Rzayev S, Özkan S, Tokcaer AB, Saka E, Durmaz Celik FN, Barut BÖ, Tüfekcioglu Z, Acarer A, Balaban H, Erer S, Dogu O, Kibaroglu S, Aydin N, Hanagasi H, Elibol B, Emre M, Stebbins GT, Goetz CG.

Mov Disord Clin Pract. 2017 Nov 16;5(1):54-59. doi: 10.1002/mdc3.12556. eCollection 2018 Jan-Feb.

5.

Use of anti-Parkinson medication during pregnancy: a case series.

Tüfekçioğlu Z, Hanağası H, Yalçın Çakmaklı G, Elibol B, Esmeli Tokuçoğlu F, Kaya ZE, Ertan S, Özekmekçi S, Emre M.

J Neurol. 2018 Aug;265(8):1922-1929. doi: 10.1007/s00415-018-8937-1. Epub 2018 Jun 20.

PMID:
29926223
6.

Residual NO modulates contractile responses and membrane potential in isolated rat mesenteric arteries.

Kıroğlu OE, Özü ÖY, Emre M, Bayel İ, Kumcu EK, Seçilmiş MA.

Nitric Oxide. 2017 Dec 1;71:21-26. doi: 10.1016/j.niox.2017.10.003. Epub 2017 Oct 12.

PMID:
29031734
7.

An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.

Uysal-Cantürk P, Hanağası HA, Bilgiç B, Gürvit H, Emre M.

Eur J Neurol. 2018 Jan;25(1):148-153. doi: 10.1111/ene.13467. Epub 2017 Oct 16.

PMID:
28941002
8.

The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN.

Olgiati S, Doğu O, Tufekcioglu Z, Diler Y, Saka E, Gultekin M, Kaleagasi H, Kuipers D, Graafland J, Breedveld GJ, Quadri M, Sürmeli R, Sünter G, Doğan T, Yalçın AD, Bilgiç B, Elibol B, Emre M, Hanagasi HA, Bonifati V.

Parkinsonism Relat Disord. 2017 Jun;39:64-70. doi: 10.1016/j.parkreldis.2017.03.012. Epub 2017 Mar 21.

PMID:
28347615
9.

Dementia in Parkinson's disease.

Hanagasi HA, Tufekcioglu Z, Emre M.

J Neurol Sci. 2017 Mar 15;374:26-31. doi: 10.1016/j.jns.2017.01.012. Epub 2017 Jan 5. Review.

PMID:
28088312
10.

Cognitive and anatomical correlates of anosognosia in amnestic mild cognitive impairment and early-stage Alzheimer's disease.

Senturk G, Bilgic B, Arslan AB, Bayram A, Hanagasi H, Gurvit H, Emre M.

Int Psychogeriatr. 2017 Feb;29(2):293-302. doi: 10.1017/S1041610216001812. Epub 2016 Oct 26.

PMID:
27780496
11.

Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients.

Guven G, Lohmann E, Bras J, Gibbs JR, Gurvit H, Bilgic B, Hanagasi H, Rizzu P, Heutink P, Emre M, Erginel-Unaltuna N, Just W, Hardy J, Singleton A, Guerreiro R.

PLoS One. 2016 Sep 15;11(9):e0162592. doi: 10.1371/journal.pone.0162592. eCollection 2016.

12.

The Association Between Clusterin and APOE Polymorphisms and Late-Onset Alzheimer Disease in a Turkish Cohort.

Alaylıoğlu M, Gezen-Ak D, Dursun E, Bilgiç B, Hanağası H, Ertan T, Gürvit H, Emre M, Eker E, Uysal Ö, Yılmazer S.

J Geriatr Psychiatry Neurol. 2016 Jul;29(4):221-6. doi: 10.1177/0891988716640373. Epub 2016 Apr 12.

PMID:
27076484
13.

Effects of GSM-like radiofrequency irradiation during the oogenesis and spermiogenesis of Xenopus laevis.

Boga A, Emre M, Sertdemir Y, Uncu İ, Binokay S, Demirhan O.

Ecotoxicol Environ Saf. 2016 Jul;129:137-44. doi: 10.1016/j.ecoenv.2016.03.015. Epub 2016 Mar 24.

PMID:
27017260
14.

A novel homozygous DJ1 mutation causes parkinsonism and ALS in a Turkish family.

Hanagasi HA, Giri A, Kartal E, Guven G, Bilgiç B, Hauser AK, Emre M, Heutink P, Basak N, Gasser T, Simón-Sánchez J, Lohmann E.

Parkinsonism Relat Disord. 2016 Aug;29:117-20. doi: 10.1016/j.parkreldis.2016.03.001. Epub 2016 Mar 3.

PMID:
26972524
15.

Adult-onset phenylketonuria with rapidly progressive dementia and parkinsonism.

Tufekcioglu Z, Cakar A, Bilgic B, Hanagasi H, Gurvit H, Emre M.

Neurocase. 2016 Jun;22(3):273-5. doi: 10.1080/13554794.2016.1142567. Epub 2016 Mar 10.

PMID:
26962957
16.

Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy.

Lesage S, Drouet V, Majounie E, Deramecourt V, Jacoupy M, Nicolas A, Cormier-Dequaire F, Hassoun SM, Pujol C, Ciura S, Erpapazoglou Z, Usenko T, Maurage CA, Sahbatou M, Liebau S, Ding J, Bilgic B, Emre M, Erginel-Unaltuna N, Guven G, Tison F, Tranchant C, Vidailhet M, Corvol JC, Krack P, Leutenegger AL, Nalls MA, Hernandez DG, Heutink P, Gibbs JR, Hardy J, Wood NW, Gasser T, Durr A, Deleuze JF, Tazir M, Destée A, Lohmann E, Kabashi E, Singleton A, Corti O, Brice A; French Parkinson's Disease Genetics Study (PDG); International Parkinson's Disease Genomics Consortium (IPDGC).

Am J Hum Genet. 2016 Mar 3;98(3):500-513. doi: 10.1016/j.ajhg.2016.01.014.

17.

Neuro-Behçet's Disease with Chorea.

Gür Özmen S, Hanağasi H, Gürvit H, Emre M, Akman Demir G.

Noro Psikiyatr Ars. 2015 Jun;52(2):200-201. doi: 10.5152/npa.2015.7316. Epub 2015 Jun 1.

18.

A new F-box protein 7 gene mutation causing typical Parkinson's disease.

Lohmann E, Coquel AS, Honoré A, Gurvit H, Hanagasi H, Emre M, Leutenegger AL, Drouet V, Sahbatou M, Guven G, Erginel-Unaltuna N, Deleuze JF, Lesage S, Brice A.

Mov Disord. 2015 Jul;30(8):1130-3. doi: 10.1002/mds.26266. Epub 2015 May 23.

PMID:
26010069
19.

Investigation of Propolis' Effect on Thiobarbituric Acid Reactive Substances and Anti-Oxidant Enzyme Levels of Hippocampus in Diabetic Rats Induced by Streptozotocin.

Köksal B, Emre MH, Polat A.

Open Access Maced J Med Sci. 2015 Mar 15;3(1):52-6. doi: 10.3889/oamjms.2015.031. Epub 2015 Mar 8.

20.

Secondary paroxysmal kinesigenic dyskinesia associated with CLCN2 gene mutation.

Hanagasi HA, Bilgiç B, Abbink TE, Hanagasi F, Tüfekçioğlu Z, Gürvit H, Başak N, van der Knaap MS, Emre M.

Parkinsonism Relat Disord. 2015 May;21(5):544-6. doi: 10.1016/j.parkreldis.2015.02.013. Epub 2015 Feb 25. No abstract available.

PMID:
25745790
21.

The effect of 900 and 1800 MHz GSM-like radiofrequency irradiation and nicotine sulfate administration on the embryonic development of Xenopus laevis.

Boga A, Emre M, Sertdemir Y, Akillioglu K, Binokay S, Demirhan O.

Ecotoxicol Environ Saf. 2015 Mar;113:378-90. doi: 10.1016/j.ecoenv.2014.12.020. Epub 2014 Dec 20.

PMID:
25531835
22.

Cognitive impairment and dementia in Parkinson's disease: practical issues and management.

Emre M, Ford PJ, Bilgiç B, Uç EY.

Mov Disord. 2014 Apr 15;29(5):663-72. doi: 10.1002/mds.25870. Review.

PMID:
24757114
23.

Supranuclear Gaze Abnormality in Sporadic-Creutzfeldt Jacob Disease.

Gür Özmen S, Gürvit H, Hanağasi HA, Alpsan Gökmen MH, Emre M.

Noro Psikiyatr Ars. 2014 Mar;51(1):91-92. doi: 10.4274/npa.y7341. Epub 2014 Mar 1. No abstract available.

24.

Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study.

Emre M, Poewe W, De Deyn PP, Barone P, Kulisevsky J, Pourcher E, van Laar T, Storch A, Micheli F, Burn D, Durif F, Pahwa R, Callegari F, Tenenbaum N, Strohmaier C.

Clin Neuropharmacol. 2014 Jan-Feb;37(1):9-16. doi: 10.1097/WNF.0000000000000010.

PMID:
24434526
25.

The Relationship of White Matter Hyperintensities with Depressive Symptoms and Daily Living Activities in Early-Stage Alzheimer's Disease Patients.

Bilgiç B, Bayram A, Hanağasi HA, Tümaç A, Uysal P, Şentürk G, Alpsan H, Lohmann E, Gürvit H, Emre M.

Noro Psikiyatr Ars. 2013 Dec;50(4):360-363. doi: 10.4274/Npa.y6603. Epub 2013 Dec 1.

26.

Neuroimaging, biomarkers, and management of dementia with lewy bodies.

Hanagasi HA, Bilgiç B, Emre M.

Front Neurol. 2013 Oct 7;4:151. doi: 10.3389/fneur.2013.00151. Review. No abstract available.

27.

Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family.

Guerreiro R, Bilgic B, Guven G, Brás J, Rohrer J, Lohmann E, Hanagasi H, Gurvit H, Emre M.

Neurobiol Aging. 2013 Dec;34(12):2890.e1-5. doi: 10.1016/j.neurobiolaging.2013.06.005. Epub 2013 Jul 17. Review.

28.

Impact of cognitive dysfunction on drooling in Parkinson's disease.

Rana AQ, Khondker S, Kabir A, Owalia A, Khondker S, Emre M.

Eur Neurol. 2013;70(1-2):42-5. doi: 10.1159/000348571. Epub 2013 May 23.

PMID:
23711510
29.

Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.

Warren Olanow C, Kieburtz K, Rascol O, Poewe W, Schapira AH, Emre M, Nissinen H, Leinonen M, Stocchi F; Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) Investigators.

Mov Disord. 2013 Jul;28(8):1064-71. doi: 10.1002/mds.25364. Epub 2013 Apr 29.

PMID:
23630119
30.

Acute effects of moderate and strenuous running on trace element distribution in the brain, liver, and spleen of trained rats.

Ergen K, Ince H, Düzova H, Karakoç Y, Emre MH.

Balkan Med J. 2013 Mar;30(1):105-10. doi: 10.5152/balkanmedj.2012.093. Epub 2013 Mar 1.

31.

Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement.

Guerreiro RJ, Lohmann E, Brás JM, Gibbs JR, Rohrer JD, Gurunlian N, Dursun B, Bilgic B, Hanagasi H, Gurvit H, Emre M, Singleton A, Hardy J.

JAMA Neurol. 2013 Jan;70(1):78-84. doi: 10.1001/jamaneurol.2013.579.

32.

The impact of magnesium on isometric twitch parameters and resting membrane potential of the skeletal muscle in diabetic rats.

Pelit A, Emre M, Dağli K, Tuli A.

Cell Biochem Biophys. 2013 Apr;65(3):315-9. doi: 10.1007/s12013-012-9434-2.

PMID:
23080019
33.

Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease.

Gezen-Ak D, Dursun E, Bilgiç B, Hanağasi H, Ertan T, Gürvit H, Emre M, Eker E, Ulutin T, Uysal O, Yilmazer S.

Tohoku J Exp Med. 2012 Nov;228(3):189-96.

34.

Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.

Dubois B, Tolosa E, Katzenschlager R, Emre M, Lees AJ, Schumann G, Pourcher E, Gray J, Thomas G, Swartz J, Hsu T, Moline ML.

Mov Disord. 2012 Sep 1;27(10):1230-8. doi: 10.1002/mds.25098. Epub 2012 Aug 22.

PMID:
22915447
35.

Effects of rosiglitazone with insulin combination therapy on oxidative stress and lipid profile in left ventricular muscles of diabetic rats.

Kavak S, Ayaz L, Emre M.

Exp Diabetes Res. 2012;2012:905683. doi: 10.1155/2012/905683. Epub 2012 Jul 5.

36.

The embryonic development of Xenopus laevis under a low frequency electric field.

Boga A, Binokay S, Emre M, Sertdemir Y.

In Vitro Cell Dev Biol Anim. 2012 Jun;48(6):385-91. doi: 10.1007/s11626-012-9519-7. Epub 2012 Jun 22.

PMID:
22723004
37.

Dementia and behavioral neurology: recent advances.

Bilgic B, Hanagasi HA, Emre M.

J Neurol. 2012 May;259(5):1006-10. doi: 10.1007/s00415-012-6460-3. Epub 2012 Apr 18. Review.

PMID:
22527221
38.

Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients.

Lohmann E, Guerreiro RJ, Erginel-Unaltuna N, Gurunlian N, Bilgic B, Gurvit H, Hanagasi HA, Luu N, Emre M, Singleton A.

Neurobiol Aging. 2012 Aug;33(8):1850.e17-27. doi: 10.1016/j.neurobiolaging.2012.02.020. Epub 2012 Apr 13.

39.

Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: contribution of automated segmentation neuroimaging method.

Bilgic B, Bayram A, Arslan AB, Hanagasi H, Dursun B, Gurvit H, Emre M, Lohmann E.

Parkinsonism Relat Disord. 2012 Jun;18(5):562-6. doi: 10.1016/j.parkreldis.2012.02.017. Epub 2012 Mar 24.

PMID:
22445249
40.

Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone.

Reichmann H, Emre M.

Expert Rev Neurother. 2012 Feb;12(2):119-31. doi: 10.1586/ern.11.203. Review. Erratum in: Expert Rev Neurother. 2012 May;12(5):628.

PMID:
22288667
41.

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.

Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M.

Mov Disord. 2012 Mar;27(3):349-56. doi: 10.1002/mds.24893. Epub 2012 Jan 24. Review.

42.

Genetic bases and phenotypes of autosomal recessive Parkinson disease in a Turkish population.

Lohmann E, Dursun B, Lesage S, Hanagasi HA, Sevinc G, Honore A, Bilgic B, Gürvit H, Dogu O, Kaleagası H, Babacan G, Yazici J, Erginel-Unaltuna N, Brice A, Emre M.

Eur J Neurol. 2012 May;19(5):769-75. doi: 10.1111/j.1468-1331.2011.03639.x. Epub 2012 Jan 10.

PMID:
22233331
43.

Perampanel in Parkinson disease fluctuations: a double-blind randomized trial with placebo and entacapone.

Rascol O, Barone P, Behari M, Emre M, Giladi N, Olanow CW, Ruzicka E, Bibbiani F, Squillacote D, Patten A, Tolosa E.

Clin Neuropharmacol. 2012 Jan-Feb;35(1):15-20. doi: 10.1097/WNF.0b013e318241520b.

PMID:
22222634
44.

Cognitive impairment in nondemented Parkinson's disease.

Barone P, Aarsland D, Burn D, Emre M, Kulisevsky J, Weintraub D.

Mov Disord. 2011 Dec;26(14):2483-95. doi: 10.1002/mds.23919. Epub 2011 Aug 24. Review.

PMID:
22170275
45.

Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease.

Guerreiro RJ, Lohmann E, Kinsella E, Brás JM, Luu N, Gurunlian N, Dursun B, Bilgic B, Santana I, Hanagasi H, Gurvit H, Gibbs JR, Oliveira C, Emre M, Singleton A.

Neurobiol Aging. 2012 May;33(5):1008.e17-23. doi: 10.1016/j.neurobiolaging.2011.10.009. Epub 2011 Dec 6.

46.

The impact of familial structure on Parkinson's disease in Istanbul Medical School, Turkey.

Lohmann E, Hanağası HA, Gürvit H, Kayacı G, Ruberg M, Yazıcı J, Emre M.

Int J Neurosci. 2012 Feb;122(2):102-5. doi: 10.3109/00207454.2011.631715. Epub 2011 Dec 1.

PMID:
21995451
47.

Crossed aphasia in a dextral patient with logopenic/phonological variant of primary progressive aphasia.

Demirtas-Tatlidede A, Gurvit H, Oktem-Tanor O, Emre M.

Alzheimer Dis Assoc Disord. 2012 Jul-Sep;26(3):282-4. doi: 10.1097/WAD.0b013e31823346c6.

PMID:
21959362
48.

LRRK2 mutations are uncommon in Turkey.

Hanagasi HA, Lohmann E, Dursun B, Honoré A, Lesage S, Dogu O, Kaleagasi H, Aydın O, Gürvit H, Erginel-Unaltuna N, Brice A, Emre M.

Eur J Neurol. 2011 Oct;18(10):e137. doi: 10.1111/j.1468-1331.2011.03471.x. No abstract available.

PMID:
21914047
49.

Influence of dihydropyridine calcium antagonist nitrendipine on benzo(a)pyrene-induced oxidative stress.

Aktay G, Emre MH, Polat A.

Arch Pharm Res. 2011 Jul;34(7):1171-5. doi: 10.1007/s12272-011-0715-x. Epub 2011 Aug 3.

PMID:
21811924
50.

Erdheim Chester disease presenting as slowly progressive cerebellar syndrome and asymptomatic widespread skeletal involvement.

Tufan F, Myftiu B, Aygun D, Keles N, Haroche J, Hanagasi H, Gurvit H, Emre M, Besisik S.

Eur J Neurol. 2011 Aug;18(8):e93. doi: 10.1111/j.1468-1331.2011.03378.x. No abstract available.

PMID:
21749566

Supplemental Content

Support Center